Bivalirudin in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary PCI

Summary

The purpose of this study is to demonstrate the benefit of bivalirudin in combination with clopidogrel with provisional GPIIb/IIIa inhibitor use, in reducing the bleeding complications associated with early invasive management of patients presenting with an ST Elevation Myocardial Infarction (STEMI) and undergoing primary PCI, while providing similar rates of ischemic events when compared to published results of relevant trials.

Timeline

Start

2004-04

Primary completion

—

Completion

2005-12

Drugs

Indications